Hara A, Matsumoto K, Yokoyama Y, Kizu J.
Factorial analysis of hepatitis B virus reactivation-induced hepatitis B using JADER.
Biol Pharm Bull. 2017;40:782-788.
Yokoyama Y, Nishino K, Matsumoto K, Inomoto Y, Matsuda K, Nakamura R, Yasuno N, Kizu J.
Dosing optimization of meropenem based on a pharmacokinetic analysis in patients receiving hemodiafiltration and an in vitro model.
J Infect Chemother. 2018;24:92-98.
松元一明. 共催セミナー2: 抗微生物薬のTDM Up to Date.
第34回日本TDM学会・学術大会, 京都, 抄録集 p92 (2017/9).
Matsumoto K. International Symposium “Expanding the Pharmacist’s Roles in Both the Finance and Delivery of Health Care Services”:
Pharmacokinetic/Pharmacodynamic Evaluation of Sulbactam against Acinetobacter baumannii Infections.
The 27th Annual Meeting of the Japanese Society of Pharmaceutical Health Care and Sciences, Chiba, Program p41 (2017/11).
Watanabe E, Shigemi A, Umezaki Y, Nakamura K, Ueno K, Ikeda R, Yokoyama Y, Matsumoto K, Ikawa K, Morikawa N, Takeda Y.
Pharmacokinetic/pharmacodynamic evaluation of teicoplanin against Staphylococcus aureus in murine thigh infection model.
15th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology, Kyoto, Japan (2017/9).
Shigemi A, Watanabe E, Umezaki Y, Ikeda R, Matsumoto K, Yokoyama Y, Ikawa K, Morikawa N, Takeda Y.
Voriconazole TDM based on both unchanged drug and metabolite concentrations in Japanese patients.
15th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology, Kyoto, Japan (2017/9).